Bromine → 5-bromo-1-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
반응식
C([O:4][C@@H:5]1[C@@H:9]([CH2:10][O:11]C(=O)C2C=CC=CC=2)[O:8][C@@H:7]([N:20]2[CH:27]=[CH:26][C:24](=[O:25])[NH:23][C:21]2=[O:22])[C@H:6]1[F:28])(=O)C.C([O-])(=O)C.[Na+].[Br:34]Br>C(O)(=O)C>[F:28][C@H:6]1[C@H:5]([OH:4])[C@@H:9]([CH2:10][OH:11])[O:8][C@H:7]1[N:20]1[CH:27]=[C:26]([Br:34])[C:24](=[O:25])[NH:23][C:21]1=[O:22]참가 물질
5
실험 절차
To a solution of 1-(3-O-acetyl-5-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)uracil (500 mg) and sodium acetate (100 mg) in 5 ml of glacial acetic acid is added a solution of bromine (240 mg) in 1 ml of glacial acetic acid. After 30 minutes at room temperature, the solvent is removed by evaporation in vacuo. Traces of acetic acid is removed by several co-evaporation with toluene. The residue is dissolved in saturated methanolic ammonia (50 ml) and the mixture is kept standing at room temperature for 2 days. The solvent is removed by evaporation in vacuo and the residue is crystallized from water to give 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-bromouracil (325 mg), m.p. 214°-216°.
후처리
- customthe solvent is removed by evaporation in vacuo
- customTraces of acetic acid is removed by several co-evaporation with toluene
- dissolutionThe residue is dissolved in saturated methanolic ammonia (50 ml)
- waitthe mixture is kept standing at room temperature for 2 days
- customThe solvent is removed by evaporation in vacuo
- customthe residue is crystallized from water
출처 및 근거
- ORD 기록
- ord-700abcba259b44b2a186b06bf9a5a35f
- 출처 데이터셋
- uspto-grants-1980_07
- 특허 번호
- US04211773
반응 노트
불러오는 중…